US › Healthcare

OPTIMIZERx Corp (OPRX)

US · Healthcare · Health Information Services

$7.59+0.80%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$20.5M

Revenue YoY

-29.8%

Net profit

$-703,000

Profit YoY

-145.9%

EPS

$0.08

EPS estimate

$0.01

Net margin

-3.4%

EPS came in at 0.08 against a street estimate of 0.01 — a beat of 700.0%.

Key statistics

Market cap

$141.8M

P/E

30.1

Forward P/E

5.8

P/B

1.09

Book value

$6.96

EPS (TTM)

$0.25

52-week high

$22.25

52-week low

$4.54

50-day MA

$7.16

200-day MA

$8.13

Beta

1.09

Analyst view

Analysts rate OPTIMIZERx Corp a buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $12.40.

Shareholding

Insiders

13.82%

Institutions

69.69%

Largest institutional holders

Fund	Stake
Whetstone Capital Advisors, LLC	8.01%
BlackRock Inc	6.18%
Royce & Associates, LP	4.71%
Vanguard Capital Management, LLC	3.64%
Kennedy Capital Management Inc	3.42%
Rice Hall James & Associates, LLC	3.37%
Blair William & Co	3.23%
State Street Corp	2.54%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OPTIMIZERx Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.